BioSpace News Archive

CooperCompanies announced it will report first quarter 2024 financial results on Thursday, February 29, 2024, at 4:15 PM ET.

Zomedica Corp. announced that Institutional Shareholder Services, a leading independent proxy voting and corporate governance advisory firm, recommends that Zomedica Corp. shareholders vote “FOR” the proposed Share Consolidation/Reverse Stock Split detailed in the Company’s definitive proxy statement filed on January 17, 2024.

Sagimet Biosciences Inc. announced the pricing of its underwritten public offering of 9,000,000 shares of its Series A common stock at a public offering price of $12.50 per share.

Taro Pharmaceutical Industries Ltd. provided unaudited financial results for the quarter and nine months ended December 31, 2023.

PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter 2023 financial results on Thursday, February 15, 2024, at 5:00 pm Eastern Time.

Titan Pharmaceuticals, Inc. announced that by letter dated January 24, 2024, the Company was notified by The Nasdaq Stock Market LLC that the Company has regained compliance with the minimum $1.00 bid price requirement and otherwise satisfies all applicable criteria for continued listing on The Nasdaq Capital Market.